Previously we published an abstract reporting the role of the proinflammatory cytokine IL-1β and its signaling cascade in glioblastoma pathogenesis and the therapeutic effect of IL-1RA and Tolcapone as anticancer agents in Proceedings of the American Association for Cancer Research Annual Meeting 2025 [17]. This evidence concerns the gene IL1B and glioblastoma.